Table 1.

Correlation between the CD206⁺ TAMs and clinical parameters (n = 72).

Parameters	No. (%)	CD206 expression
	All	low	high	aP
Age	59 ± 9.11	57 ± 8.56	61 ± 9.45	0.121
Female	11 (15.3%)	5 (13.9%)	6 (16.7%)	0.743
Smoking	17 (23.6%)	9 (25%)	8 (22.2%)	0.781
Tumor site
Left lung	35 (48.6%)	18 (50%)	17 (47.2%)	0.814
Right lung	37 (51.4%)	18 (50%)	16 (52.8%)
Tumor size, cm
≥5	27 (37.9%)	12 (33.3%)	15 (41.7%)	0.523
<5	45 (62.1%)	24 (66.7%)	21 (58.3%)
Tumor stage
Limited stage	59 (81.9%)	31 (86.1%)	28 (77.8%)	0.358
Extensive stage	13 (18.1%)	5 (13.9%)	8 (22.2%)
Metastasis	56 (77.8%)	24 (66.7%)	32 (88.9%)	0.023*
Overall	72 (100%)	36 (50%)	36 (50%)

Data were expressed as average ± standard deviation (SD) for continuous variables and count (percentage) for categorical variables. Boldface type indicates statistical significance.

^aP-values indicate differences between CD206-high and CD206-low expressed patients.

*P < 0.05.